RPRX vs. GILD
RPRX (Royalty Pharma plc) and GILD (Gilead Sciences, Inc.) are both stocks. Both are in the Healthcare sector — RPRX in Biotechnology, GILD in Drug Manufacturers - General. Over the past 5 years, RPRX returned 11.84%/yr vs 18.56%/yr for GILD. Their 0.30 correlation means their historical movements had little consistent relationship.
Performance
RPRX vs. GILD - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RPRX achieves a 49.39% return, which is significantly higher than GILD's 11.55% return.
RPRX
- 1D
- -2.16%
- 1M
- -1.04%
- 6M
- 36.27%
- YTD
- 49.39%
- 1Y
- 57.36%
- 3Y*
- 26.46%
- 5Y*
- 11.84%
- 10Y*
- —
- ALL TIME*
- 6.64%
GILD
- 1D
- 3.13%
- 1M
- 3.03%
- 6M
- -4.44%
- YTD
- 11.55%
- 1Y
- 21.19%
- 3Y*
- 23.80%
- 5Y*
- 18.56%
- 10Y*
- 9.13%
- ALL TIME*
- 18.64%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $883.63M | $898.88M | $999.96M | |
| $150.55M | $157.50M | $200.50M |
RPRX vs. GILD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
RPRX Royalty Pharma plc | 49.39% | 55.29% | -6.36% | -27.08% | 0.99% | -19.09% | 14.62% |
GILD Gilead Sciences, Inc. | 11.55% | 36.59% | 18.68% | -1.99% | 23.63% | 29.95% | -19.51% |
Correlation
The correlation between RPRX and GILD is 0.44, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.44 |
Correlation (3Y) Balances recent behavior with more history. | 0.38 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.36 |
Correlation (All Time) Calculated using the full available price history since Jun 16, 2020 | 0.30 |
The correlation between RPRX and GILD shifts across timeframes, from 0.30 (all time) to 0.44 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
RPRX:
$24.59B
GILD:
$167.92B
RPRX:
$2.22
GILD:
$4.18
RPRX:
25.77
GILD:
32.32
RPRX:
0.03
GILD:
0.08
RPRX:
8.74
GILD:
5.56
RPRX:
$2.44B
GILD:
$30.46B
RPRX:
$1.81B
GILD:
$12.58B
RPRX:
$1.70B
GILD:
-$53.00M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RPRX vs. GILD — Risk / Return Rank
RPRX
GILD
RPRX vs. GILD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Royalty Pharma plc (RPRX) and Gilead Sciences, Inc. (GILD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| RPRX | GILD | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.72 | ||
| Sortino ratioReturn per unit of downside risk | +1.91 | ||
| Omega ratioGain probability vs. loss probability | 1.42 | 1.15 | +0.27 |
| Calmar ratioReturn relative to maximum drawdown | 7.81 | 0.99 | +6.82 |
| Martin ratioReturn relative to average drawdown | 19.00 | 2.23 | +16.77 |
Loading charts...
Drawdowns
RPRX vs. GILD - Drawdown Comparison
The maximum RPRX drawdown since its inception was -49.68%, smaller than the maximum GILD drawdown of -70.83%. Use the drawdown chart below to compare losses from any high point for RPRX and GILD.
Loading charts...
Drawdown Indicators
| RPRX | GILD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -49.68% | -70.83% | +21.15% |
Max Drawdown (1Y)Largest decline over 1 year | -7.38% | -21.59% | +14.21% |
Max Drawdown (3Y)Largest decline over 3 years | -20.67% | -26.59% | +5.92% |
Max Drawdown (5Y)Largest decline over 5 years | -41.98% | -26.59% | -15.39% |
Max Drawdown (10Y)Largest decline over 10 years | — | -30.47% | — |
Current DrawdownCurrent decline from peak | -4.67% | -12.12% | +7.45% |
Average DrawdownAverage peak-to-trough decline | -25.76% | -22.13% | -3.63% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.03% | 9.55% | -6.52% |
Volatility
RPRX vs. GILD - Volatility Comparison
The current volatility for Royalty Pharma plc (RPRX) is 7.28%, while Gilead Sciences, Inc. (GILD) has a volatility of 9.59%. This indicates that RPRX experiences smaller price fluctuations and is considered to be less risky than GILD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RPRX | GILD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.28% | 9.59% | -2.31% |
Volatility (6M)Calculated over the trailing 6-month period | 15.88% | 19.45% | -3.57% |
Volatility (1Y)Calculated over the trailing 1-year period | 23.03% | 27.14% | -4.11% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 23.86% | 24.57% | -0.71% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 26.85% | 25.48% | +1.37% |
Dividends
RPRX vs. GILD - Dividend Comparison
RPRX's dividend yield for the trailing twelve months is around 1.59%, less than GILD's 2.38% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GILD Gilead Sciences, Inc. | 2.38% | 2.57% | 3.33% | 3.70% | 3.40% | 3.91% | 4.67% | 3.88% | 3.65% | 2.90% | 2.57% | 1.27% |
RPRX Royalty Pharma plc | 1.59% | 2.28% | 3.29% | 2.85% | 1.92% | 1.71% | 0.60% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
RPRX vs. GILD - Financials Comparison
This section allows you to compare key financial metrics between Royalty Pharma plc and Gilead Sciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
RPRX and GILD have a correlation of 0.44, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
GILD has higher volatility (9.59%) compared to RPRX (7.28%). In terms of maximum drawdown, RPRX dropped -49.68% vs GILD's -70.83%.
RPRX currently has the higher Sharpe Ratio (2.51 vs 0.78), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RPRX and GILD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer